Related references
Note: Only part of the references are listed.Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole
C. Devine et al.
PARASITOLOGY (2010)
Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole
Catherine Devine et al.
PARASITOLOGY RESEARCH (2010)
Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica
Catherine Devine et al.
PARASITOLOGY RESEARCH (2010)
Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep
G. Virkel et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica
C. Devine et al.
PARASITOLOGY (2009)
Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha
M. McConville et al.
PARASITOLOGY (2009)
Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica
L. Halferty et al.
VETERINARY PARASITOLOGY (2009)
Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha
A. McConville et al.
VETERINARY PARASITOLOGY (2008)
Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax)
B. McKinstry et al.
PARASITOLOGY RESEARCH (2007)
Fasciola hepatica:: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke
M. Meaney et al.
PARASITOLOGY RESEARCH (2007)
Fasciola hepatica:: morphological effects of a combination of triclabendazole and clorsulon against mature fluke
M. Meaney et al.
PARASITOLOGY RESEARCH (2006)
Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses
SFS Bruni et al.
EQUINE VETERINARY JOURNAL (2005)
Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes
LI Alvarez et al.
PARASITOLOGY (2005)
Benzimidazole drugs and modulation of biotransformation enzymes
J Velík et al.
RESEARCH IN VETERINARY SCIENCE (2004)
The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica
MW Robinson et al.
PARASITOLOGY RESEARCH (2004)
Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon
M Meaney et al.
PARASITOLOGY RESEARCH (2004)
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro
SM Walker et al.
PARASITOLOGY RESEARCH (2004)
Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica
L Mottier et al.
XENOBIOTICA (2004)
Fasciola hepatica:: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax)
B McKinstry et al.
PARASITOLOGY RESEARCH (2003)
Fasciola hepatica:: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes
M Meaney et al.
PARASITOLOGY RESEARCH (2003)
Fasciola hepatica:: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen')
JF Buchanan et al.
PARASITOLOGY (2003)
Fenbendazole pharmacokinetics, metabolism, and potentiation in horses
QA McKellar et al.
DRUG METABOLISM AND DISPOSITION (2002)
Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep
S Sánchez et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2002)
Share Paper
